IP Library Granted Patent US 8,771,217
Granted Patent B2
US 8,771,217 · App. 12/966,889 · Granted Jul 8, 2014

Shunt device and method for treating ocular disorders

Inventors: Mary G Lynch (Atlanta, GA); Reay H Brown (Atlanta, GA)
Assignee: Glaukos Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,771,217
App. No.
12/966,889
Granted
Jul 8, 2014
Kind
B2
Abstract

Shunt devices and a method for continuously decompressing elevated intraocular pressure in eyes affected by glaucoma by diverting excess aqueous humor from the anterior chamber of the eye into Schlemm's canal where post-operative patency can be maintained with an indwelling shunt device which surgically connects the canal with the anterior chamber. The shunt devices provide uni- or bi-directional flow of aqueous humor into Schlemm's canal.

Claims (23)

1. An implant of biocompatible material for treating glaucoma, comprising:

a body having a flow passage which conducts fluid from an anterior chamber of an eye to Schlemm's canal of the eye;

said body being configured so as to have an axis extending away from the canal when implanted;

said body having at least first and second surface portions within Schlemm's canal that extend transversely to said axis on opposite sides of the axis.

2. The implant of claim 1 , wherein the surface portions are disposed on the implant so as to contact a trabecular meshwork of the eye when implanted.

3. The implant of claim 1 , wherein the surface portions are disposed on the implant so as to contact scleral tissue.

4. The implant of claim 1 , wherein the axis further comprises a terminal aspect angulated to face away from the iris.

5. The implant of claim 1 , wherein the body further comprises a valve.

6. The implant of claim 1 , wherein the implant generally has a T shape.

7. The implant of claim 1 , wherein at least a portion of the implant is comprised of a solid material.

8. The implant of claim 7 , wherein the solid material is porous.

9. The implant of claim 1 , wherein at least a portion of the implant comprises a mesh material.

10. The implant of claim 1 , wherein at least a portion of the implant is fenestrated.

11. The implant of claim 1 , wherein the body is configured so that the axis extends substantially perpendicular to the canal when implanted.

12. The implant of claim 1 , wherein the body defines at least one fluid directing channel.

13. The implant of claim 12 , wherein the channel includes an opening disposed adjacent a surface of the canal when implanted.

14. The implant of claim 13 , wherein the opening is disposed adjacent scleral tissue when implanted.

15. The implant of claim 12 , wherein the channel has a maximum width in the range from about 0.2 mm to about 0.5 mm.

16. The implant of claim 1 , wherein at least a portion of the implant is comprised of a flexible material.

17. The implant of claim 1 , wherein at least a portion of the body is curved.

18. The implant of claim 1 , wherein the body comprises a plurality of outlets.

19. The implant of claim 1 , wherein the body comprises a plurality of open areas.

20. The implant of claim 12 , wherein the length of the fluid directing channel is about 1 mm to about 3 mm.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2014
From: GMP VISION SOLUTIONS, INC.
To: GLAUKOS CORPORATION
Reel/Frame 032941/0179 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2014
From: LYNCH, MARY G.; BROWN, REAY H.
To: GMP VISION SOLUTIONS, INC.
Reel/Frame 032974/0674 →
Continuity (6)
Division 10987114 · Nov 12, 2004
Continuation 10445740 · May 27, 2003
Continuation 10242385 · Sep 12, 2002
Continuation 09558505 · Apr 26, 2000
Provisional Application 60131030 · Apr 26, 1999
Related Publication 20110196281A1 · Aug 11, 2011